Jorge Augusto Petroli Marchesi
Research Subjects
Jorge Augusto Petroli Marchesi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Back
MercoLab Laboratórios, Cascavel 85816-280, PR, Brazil
1 shared publication - Daiane Voss-Rech
EMBRAPA Suínos e Aves, Concórdia, Brazil
1 shared publication - Gabriel da Silva Zani
Universidade Federal de Pelotas
1 shared publication - Iara Maria Trevisol
Embrapa Swine and Poultry, Brazilian Agricultural Research Corporation, Concórdia, 89715-899 SC, Brazil
1 shared publication - Luizinho Caron
Embrapa Suinos e Aves, Brazil
1 shared publication - Marcos Antônio Zanella Mores
EMBRAPA Suínos e Aves, Concórdia, Brazil
1 shared publication
Latest Publications
- Open Access
Pathogenicity of GI-23 Avian Infectious Bronchitis Virus Strain Isolated in Brazil
IBV variants belonging to the GI-23 lineage have circulated since 1998 in the Middle East and have spread to several countries over time. In Brazil, the first report of GI-23 occurred in 2022. The study aimed to evaluate the in vivo pathogenicity of exotic variant GI-23 isolates. Biological samples were screening by real-time RT-PCR and classified in to GI-1 or G1-11 lineages. Interestingly, 47.77% were not classified in these lineages. Nine of the unclassified strains were sequenced and showed a high similarity to the GI-23 strain. All nine were isolated and three, were studied for pathogenicity. At necropsy, the main observations were the presence of mucus in the trachea and congestion in the tracheal mucosa. In addition, lesions on the tracheas showed marked ciliostasis, and the ciliary activity confirmed the high pathogenicity of isolates. This variant is highly pathogenic to the upper respiratory tract and can cause severe kidney lesions. This study confirm a circulation of GI-23 strain in the country and report, to first time, the isolation of an exotic variant of IBV in Brazil.
Open AccessPathogenicity of GI-23 Avian Infectious Bronchitis Virus Strain Isolated in Brazil
IBV variants belonging to the GI-23 lineage have circulated since 1998 in the Middle East and have spread to several countries over time. In Brazil, the first report of GI-23 occurred in 2022. The study aimed to evaluate the in vivo pathogenicity of exotic variant GI-23 isolates. Biological samples were screening by real-time RT-PCR and classified in to GI-1 or G1-11 lineages. Interestingly, 47.77% were not classified in these lineages. Nine of the unclassified strains were sequenced and showed a high similarity to the GI-23 strain. All nine were isolated and three, were studied for pathogenicity. At necropsy, the main observations were the presence of mucus in the trachea and congestion in the tracheal mucosa. In addition, lesions on the tracheas showed marked ciliostasis, and the ciliary activity confirmed the high pathogenicity of isolates. This variant is highly pathogenic to the upper respiratory tract and can cause severe kidney lesions. This study confirm a circulation of GI-23 strain in the country and report, to first time, the isolation of an exotic variant of IBV in Brazil.